ResearcherOslo University HospitalActive in the last 2 years
Pål‐Dag Line
Matched on ORCID iD 0000-0002-5884-9336; OpenAlex author ID A5086349004. Sources: ClinicalTrials.gov.
Their work
- Papers
- 4
- Trials
- 1
- Grants
- 0
- Labs led
- 0
- Collaborators
- 11
2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper · 2024: none · 2025: 2 papers, 1 trial
Papers 4
- Anatomical Classification and Staging Systems of Borderline Resectable and Locally Advanced Pancreatic Cancer-A Subgroup Analysis of the NORPACT-2 Trial. Co-author DOI 10.1245/s10434-025-17527-y↗
- Surgical, Histopathological, and Quality of Life Outcomes Following Neoadjuvant Chemotherapy and Pancreatectomy for Borderline Resectable and Locally Advanced … Co-author DOI 10.3390/cancers17152505↗
- Resection rates and intention-to-treat outcomes in borderline and locally advanced pancreatic cancer: real-world data from a population-based, prospective coho… Co-author DOI 10.1093/bjsopen/zrad137↗
- Regulatory T cells that co-express RORγt and FOXP3 are pro-inflammatory and immunosuppressive and expand in human pancreatic cancer. Co-author DOI 10.1080/2162402x.2015.1102828↗
Trials 1
Closest collaborators
The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Knut Jørgen Labori · 4 shared papers, 2016–2025 · strength 0.76
- Paper Anatomical Classification and Staging Systems of Borderline Resectable and Locally Advanced Pancreatic Cancer-A Subgrou… DOI 10.1245/s10434-025-17527-y↗
- Paper Surgical, Histopathological, and Quality of Life Outcomes Following Neoadjuvant Chemotherapy and Pancreatectomy for Bor… DOI 10.3390/cancers17152505↗
- Paper Resection rates and intention-to-treat outcomes in borderline and locally advanced pancreatic cancer: real-world data f… DOI 10.1093/bjsopen/zrad137↗
- Dyre Berg Kleive · 3 shared papers, 2023–2025 · strength 0.70
- Paper Anatomical Classification and Staging Systems of Borderline Resectable and Locally Advanced Pancreatic Cancer-A Subgrou… DOI 10.1245/s10434-025-17527-y↗
- Paper Surgical, Histopathological, and Quality of Life Outcomes Following Neoadjuvant Chemotherapy and Pancreatectomy for Bor… DOI 10.3390/cancers17152505↗
- Paper Resection rates and intention-to-treat outcomes in borderline and locally advanced pancreatic cancer: real-world data f… DOI 10.1093/bjsopen/zrad137↗
- Ingvild Farnes · 3 shared papers, 2023–2025 · strength 0.70
- Paper Anatomical Classification and Staging Systems of Borderline Resectable and Locally Advanced Pancreatic Cancer-A Subgrou… DOI 10.1245/s10434-025-17527-y↗
- Paper Surgical, Histopathological, and Quality of Life Outcomes Following Neoadjuvant Chemotherapy and Pancreatectomy for Bor… DOI 10.3390/cancers17152505↗
- Paper Resection rates and intention-to-treat outcomes in borderline and locally advanced pancreatic cancer: real-world data f… DOI 10.1093/bjsopen/zrad137↗
- Caroline Sophie Verbeke · 3 shared papers, 2023–2025 · strength 0.70
- Paper Anatomical Classification and Staging Systems of Borderline Resectable and Locally Advanced Pancreatic Cancer-A Subgrou… DOI 10.1245/s10434-025-17527-y↗
- Paper Surgical, Histopathological, and Quality of Life Outcomes Following Neoadjuvant Chemotherapy and Pancreatectomy for Bor… DOI 10.3390/cancers17152505↗
- Paper Resection rates and intention-to-treat outcomes in borderline and locally advanced pancreatic cancer: real-world data f… DOI 10.1093/bjsopen/zrad137↗
- Jacob Ghotbi · 1 shared paper, 2025 · strength 0.27
- Lars Aabakken · 1 shared paper, 2023 · strength 0.18
- Svein Dueland · 1 shared paper, 2023 · strength 0.18
- Gro Wiedswang · 1 shared paper, 2016 · strength 0.06
- Einar Martin Aandahl · 1 shared paper, 2016 · strength 0.06
- Harald Hugenschmidt · 1 shared paper, 2016 · strength 0.06
- Stalin Chellappa · 1 shared paper, 2016 · strength 0.06
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.